Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

57.09USD
17 Apr 2014
Price Change (% chg)

$-0.53 (-0.92%)
Prev Close
$57.62
Open
$57.54
Day's High
$58.22
Day's Low
$56.96
Volume
86,279
Avg. Vol
133,506
52-wk High
$62.49
52-wk Low
$40.31

CRL.N

Chart for CRL.N

About

Charles River Laboratories International, Inc. is a global provider of solutions, which accelerate the early-stage drug discovery and development process. The focus of its business is in vivo biology; its portfolio includes research models and services required to enable in vivo drug discovery and development. The Company... (more)

Overall

Beta: 0.93
Market Cap (Mil.): $2,757.11
Shares Outstanding (Mil.): 48.29
Dividend: --
Yield (%): --

Financials

Search Stocks

Charles River to buy Galapagos drug service operations

BRUSSELS, March 13 - Belgian biotechnology group Galapagos said on Thursday it had agreed to sell its drug discovery service businesses to Charles River Laboratories International for up to 134 million euros ($186.3 million).

13 Mar 2014

BRIEF-Galapagos says Charles River Labs to acquire co's argenta, biofocus service ops

BRUSSELS, March 13 - Galapagos NV : * Charles River Laboratories to acquire Galapagos' argenta and biofocus service operations for up to EUR134 million * Says earnout of EUR5 million upon achievement of revenue target after 12 months * Management guidance for 2014 group revenues of EUR125 million and year end cash of EUR170 million * Says proceeds to be used to progress galapagos' pipeline * Charles River agrees to pay Galapagos immediate cash consideration of EUR129 million * Sa

13 Mar 2014

Earnings vs. Estimates

Search Stocks